PFIZER INC — Major Shareholding Notification 2000

Dec 19, 2000

SC 13G 1 genvec_13g.htm PFIZER INC. 13G - GENVEC INC. Pfizer Inc. Form 3 - Genvec, Inc.

| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 |
| --- |
| SCHEDULE 13G UNDER THE SECURITIES
EXCHANGE COMMISSION ACT OF 1934 (AMENDMENT NO.
)* |
| Genvec, Inc. (Name of Issuer) |
| Common Stock, $.001 Par Value (Title of Class of Securities) 37246C109 (CUSIP Number) |
| December 15, 2000 (Date of Event Which Requires Filing of this Statement) |
| Check the appropriate box to designate the
rule pursuant to which this Schedule is filed: [ ] Rule 13d-1 (b) [x ] Rule 13d-1 (c) [ ] Rule 13d-1(d) * The remainder of this cover page shall
be filled out for a reporting person's initial filing on this form with
respect to the subject class of securities, and for any subsequent amendment
containing information which would alter the disclosures provided in
a prior cover page. The information required in the remainder
of this cover page shall not be deemed to be "filed" for the
purpose of Section 18 of the Securities Exchange Act of 1934 ("Act")
or otherwise subject to the liabilities of that section of the Act but
shall be subject to all other provisions of the Act (however, see the
Notes). |

CUSIP NO. 37246C109 ____________ 1. NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY). Pfizer Inc. 13-5315170 ___________ 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) &nbsp (a)_ (b) _________ 3. SEC USE ONLY ___________ 4. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware _________ 5. SOLE VOTING POWER 1,925,439 NUMBER OF _________ SHARES 6. SHARED VOTING POWER BENEFICIALLY 0 OWNED BY ________ EACH 7. SOLE DISPOSITIVE POWER REPORTING 1,925,439 PERSON _______ WITH 8. SHARED DISPOSITIVE POWER 0 _________ 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,925,439 _________ 10. CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) ___________ 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 10.8% __________ 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO ________________ ITEM 1. (a) Name of Issuer: Genvec, Inc. (b) Address of Issuer's Principal Executive Offices: 65 West Watkins Mill Road Gaithersburg, MD 20878 I TEM 2. (a) Name of Person Filing: Pfizer Inc. (b) Address of Principal Business Office or, if none , Residence: 235 East 42nd Street New York, NY 10017 (c) Citizenship: Delaware (d) Title of Class of Securities: Common Stock, $.001 Par Value (e) CUSIP Number: 37246C109 ITEM 3. I F THIS STATEMENT IS FILED PURSUANT TO RULE 13d-1 (b) OR RULE 13d-2 b) OR (c), CHECK WHETHER THE PERSON FILING IS A: Not applicable ITEM 4. OWNERSHIP (a) Amount beneficially owned: 1,925,439 (b) Percent of class: 10.8% (c) Number of shares as to which the person has: (i) Sole power to vote or to direct the vote: 1,925,439 (ii) Shared power to vote or to direct the vote: 0 (iii) Sole power to dispose or to direct the disposition of: 1,925,439 (iv) Shared power to dispose or to direct the disposition of: 0 ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS Not applicable ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON Not applicable ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY See Note (1) ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP Not applicable ITEM 9. NOTICE OF DISSOLUTION OF GROUP Not applicable ITEM 10. CERTIFICATIONS By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

| PFIZER INC. |
| --- |
| Date: December 19, 2000 Pfizer Inc. By: /s/ MARGARET
M. FORAN Name: Margaret M. Foran Title: Vice President
- Corporate Governance and Assistant
Secretary |

Note (1) These shares are held by Warner-Lambert Company, a wholly owned subsidiary of Pfizer Inc.